A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study

A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study

Abstract Background The concordance rate of human epidermal growth factor receptor 2 (HER2) status between core needle biopsy (CNB) and subsequent excisional biopsies of the same tumor varies from 81 to 96%, which may cause inappropriate neoadjuvant therapy that impair the potential benefit from HER...

Full description

Bibliographic Details
Main Authors: Huimin Zhang, Peiling Xie, Zhuoying Li, Rong Huang, Weiliang Feng, Yanan Kong, Feng Xu, Lin Zhao, Qingkun Song, Jing Li, Baoning Zhang, Jinhu Fan, Youlin Qiao, Xiaoming Xie, Shan Zheng, Jianjun He, Ke Wang
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Diagnostic Pathology
Subjects:
Breast cancer
HER2 status
Nomogram
Prediction and validation
Online Access:http://link.springer.com/article/10.1186/s13000-019-0806-4

Internet

http://link.springer.com/article/10.1186/s13000-019-0806-4

Similar Items